Dr. Chris Basler, a world-renowned research leader in the study of emerging viruses, including the Ebola virus, has been named founding director of the Center for Microbial Pathogenesis, Institute for Biomedical Sciences, at Georgia State University.
An enzyme involved in glucose metabolism in cells plays a major role in the early steps of wound healing, a finding that could lead to new therapeutic approaches for wound care, according to researchers at Georgia State University.
Nearly 70 percent of Rwandans have cell phones, but only a small fraction have reliable electricity. How one entrepreneur is using solar energy to solve infrastructure problems that have plagued the country for decades.
As Atlanta and other U.S. cities await the arrival of Google Fiber, many small towns still don’t have basic broadband access.
A Georgia State University biologist has received a four-year, $1.37 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases, a division of the National Institutes of Health, to identify a novel therapeutic target in obesity.
Cheryl Johnson’s groundbreaking work is creating ripple effects internationally.
Small proteins that affect communication between cells play an important role in regulating inflammation that occurs during inflammatory bowel disease, according to researchers at Georgia State University, Emory University, the University of Michigan and Amgen, a biotechnology company.
There is no evidence of genetic overlap between risk for schizophrenia and brain volume measures, according to researchers in a global study that examined the genes that drive the development of schizophrenia.
A team of Georgia State University researchers is fighting cancers using a combination of therapies and recently found ways that radiation could maximize responses to novel immune-based therapeutic approaches to fight cancer.
Send this to a friend
